The global Insomnia Therapy market size was estimated at USD 2900 million in 2024 and is projected to reach USD 4576.57 million by 2032, exhibiting a CAGR of 5.20% during the forecast period.
North America Insomnia Therapy market size was estimated at USD 824.52 million in 2024, at a CAGR of 4.46% during the forecast period of 2025 through 2032.
Report Overview
Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
This report provides a deep insight into the global Insomnia Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Insomnia Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Insomnia Therapy market in any manner.
Global Insomnia Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Merck & Co.
- Sanofi
- Pfizer
- Takeda Pharmaceutical Company Ltd.
- Purdue Pharmaceuticals L.P.
- Eisai
- Co. Ltd.
- Meda Consumer Healthcare
- Pernix Therapeutics
- Vanda Pharmaceuticals
- ECR Pharmaceuticals
- Fidia Farmaceutici
- Dainippon Sumitomo
- Biocodex
- Eli Lilly and Company
- Ebb Therapeutics
Market Segmentation (by Type)
- Non-pharmacological Therapy
- Pharmacological Therapy
Market Segmentation (by Application)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Insomnia Therapy Market
- Overview of the regional outlook of the Insomnia Therapy Market:
FAQs on the Global Insomnia Therapy Market (2024-2032)
1. What is the expected market size of the Insomnia Therapy industry by 2032?
- The global Insomnia Therapy market is projected to reach USD 4,576.57 million by 2032, growing at a CAGR of 5.20% from 2024 to 2032.
2. What was the estimated market size of the Insomnia Therapy industry in 2024?
- In 2024, the global Insomnia Therapy market was valued at USD 2,900 million, driven by rising cases of sleep disorders and increasing demand for effective treatment solutions.
3. What factors are driving the growth of the Insomnia Therapy market?
The key growth drivers include:
- Rising prevalence of insomnia due to stress, lifestyle changes, and mental health issues.
- Advancements in sleep disorder treatments, including cognitive behavioral therapy and novel drug developments.
- Increased awareness and accessibility to insomnia management solutions.
- Growing geriatric population, which is more prone to sleep disorders.
4. What are the major types of Insomnia Therapy available in the market?
The market primarily consists of:
- Pharmacological treatments (e.g., sedative-hypnotics, benzodiazepines, antidepressants).
- Non-pharmacological therapies (e.g., Cognitive Behavioral Therapy for Insomnia (CBT-I), relaxation techniques, lifestyle modifications).
5. Which regions are expected to dominate the Insomnia Therapy market?
- North America is expected to lead due to high awareness, advanced healthcare infrastructure, and increasing cases of chronic insomnia. However, Asia-Pacific is projected to grow significantly due to rising healthcare investments and increasing diagnosis rates.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
- In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
- Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
- Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Insomnia Therapy Market and its likely evolution in the short to mid-term, and long term.
- Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
- Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
- Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
- Chapter 9 shares the main producing countries of Insomnia Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
- Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
- Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
- Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
- Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Insomnia Therapy
1.2 Key Market Segments
1.2.1 Insomnia Therapy Segment by Type
1.2.2 Insomnia Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Insomnia Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Insomnia Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Insomnia Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Insomnia Therapy Market Competitive Landscape
3.1 Global Insomnia Therapy Sales by Manufacturers (2019-2025)
3.2 Global Insomnia Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Insomnia Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Insomnia Therapy Sales Sites, Area Served, Product Type
3.6 Insomnia Therapy Market Competitive Situation and Trends
3.6.1 Insomnia Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Insomnia Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Insomnia Therapy Industry Chain Analysis
4.1 Insomnia Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Insomnia Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Insomnia Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Insomnia Therapy Sales Market Share by Type (2019-2025)
6.3 Global Insomnia Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Insomnia Therapy Price by Type (2019-2025)
7 Insomnia Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Insomnia Therapy Market Sales by Application (2019-2025)
7.3 Global Insomnia Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Insomnia Therapy Sales Growth Rate by Application (2019-2025)
8 Insomnia Therapy Market Consumption by Region
8.1 Global Insomnia Therapy Sales by Region
8.1.1 Global Insomnia Therapy Sales by Region
8.1.2 Global Insomnia Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Insomnia Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Insomnia Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Insomnia Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Insomnia Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Insomnia Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Insomnia Therapy Market Production by Region
9.1 Global Production of Insomnia Therapy by Region (2019-2025)
9.2 Global Insomnia Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Insomnia Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Insomnia Therapy Production
9.4.1 North America Insomnia Therapy Production Growth Rate (2019-2025)
9.4.2 North America Insomnia Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Insomnia Therapy Production
9.5.1 Europe Insomnia Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Insomnia Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Insomnia Therapy Production (2019-2025)
9.6.1 Japan Insomnia Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Insomnia Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Insomnia Therapy Production (2019-2025)
9.7.1 China Insomnia Therapy Production Growth Rate (2019-2025)
9.7.2 China Insomnia Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Merck and Co.
10.1.1 Merck and Co. Insomnia Therapy Basic Information
10.1.2 Merck and Co. Insomnia Therapy Product Overview
10.1.3 Merck and Co. Insomnia Therapy Product Market Performance
10.1.4 Merck and Co. Business Overview
10.1.5 Merck and Co. Insomnia Therapy SWOT Analysis
10.1.6 Merck and Co. Recent Developments
10.2 Sanofi
10.2.1 Sanofi Insomnia Therapy Basic Information
10.2.2 Sanofi Insomnia Therapy Product Overview
10.2.3 Sanofi Insomnia Therapy Product Market Performance
10.2.4 Sanofi Business Overview
10.2.5 Sanofi Insomnia Therapy SWOT Analysis
10.2.6 Sanofi Recent Developments
10.3 Pfizer
10.3.1 Pfizer Insomnia Therapy Basic Information
10.3.2 Pfizer Insomnia Therapy Product Overview
10.3.3 Pfizer Insomnia Therapy Product Market Performance
10.3.4 Pfizer Insomnia Therapy SWOT Analysis
10.3.5 Pfizer Business Overview
10.3.6 Pfizer Recent Developments
10.4 Takeda Pharmaceutical Company Ltd.
10.4.1 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Basic Information
10.4.2 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Overview
10.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Market Performance
10.4.4 Takeda Pharmaceutical Company Ltd. Business Overview
10.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
10.5 Purdue Pharmaceuticals L.P.
10.5.1 Purdue Pharmaceuticals L.P. Insomnia Therapy Basic Information
10.5.2 Purdue Pharmaceuticals L.P. Insomnia Therapy Product Overview
10.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Product Market Performance
10.5.4 Purdue Pharmaceuticals L.P. Business Overview
10.5.5 Purdue Pharmaceuticals L.P. Recent Developments
10.6 Eisai
10.6.1 Eisai Insomnia Therapy Basic Information
10.6.2 Eisai Insomnia Therapy Product Overview
10.6.3 Eisai Insomnia Therapy Product Market Performance
10.6.4 Eisai Business Overview
10.6.5 Eisai Recent Developments
10.7 Co. Ltd.
10.7.1 Co. Ltd. Insomnia Therapy Basic Information
10.7.2 Co. Ltd. Insomnia Therapy Product Overview
10.7.3 Co. Ltd. Insomnia Therapy Product Market Performance
10.7.4 Co. Ltd. Business Overview
10.7.5 Co. Ltd. Recent Developments
10.8 Meda Consumer Healthcare
10.8.1 Meda Consumer Healthcare Insomnia Therapy Basic Information
10.8.2 Meda Consumer Healthcare Insomnia Therapy Product Overview
10.8.3 Meda Consumer Healthcare Insomnia Therapy Product Market Performance
10.8.4 Meda Consumer Healthcare Business Overview
10.8.5 Meda Consumer Healthcare Recent Developments
10.9 Pernix Therapeutics
10.9.1 Pernix Therapeutics Insomnia Therapy Basic Information
10.9.2 Pernix Therapeutics Insomnia Therapy Product Overview
10.9.3 Pernix Therapeutics Insomnia Therapy Product Market Performance
10.9.4 Pernix Therapeutics Business Overview
10.9.5 Pernix Therapeutics Recent Developments
10.10 Vanda Pharmaceuticals
10.10.1 Vanda Pharmaceuticals Insomnia Therapy Basic Information
10.10.2 Vanda Pharmaceuticals Insomnia Therapy Product Overview
10.10.3 Vanda Pharmaceuticals Insomnia Therapy Product Market Performance
10.10.4 Vanda Pharmaceuticals Business Overview
10.10.5 Vanda Pharmaceuticals Recent Developments
10.11 ECR Pharmaceuticals
10.11.1 ECR Pharmaceuticals Insomnia Therapy Basic Information
10.11.2 ECR Pharmaceuticals Insomnia Therapy Product Overview
10.11.3 ECR Pharmaceuticals Insomnia Therapy Product Market Performance
10.11.4 ECR Pharmaceuticals Business Overview
10.11.5 ECR Pharmaceuticals Recent Developments
10.12 Fidia Farmaceutici
10.12.1 Fidia Farmaceutici Insomnia Therapy Basic Information
10.12.2 Fidia Farmaceutici Insomnia Therapy Product Overview
10.12.3 Fidia Farmaceutici Insomnia Therapy Product Market Performance
10.12.4 Fidia Farmaceutici Business Overview
10.12.5 Fidia Farmaceutici Recent Developments
10.13 Dainippon Sumitomo
10.13.1 Dainippon Sumitomo Insomnia Therapy Basic Information
10.13.2 Dainippon Sumitomo Insomnia Therapy Product Overview
10.13.3 Dainippon Sumitomo Insomnia Therapy Product Market Performance
10.13.4 Dainippon Sumitomo Business Overview
10.13.5 Dainippon Sumitomo Recent Developments
10.14 Biocodex
10.14.1 Biocodex Insomnia Therapy Basic Information
10.14.2 Biocodex Insomnia Therapy Product Overview
10.14.3 Biocodex Insomnia Therapy Product Market Performance
10.14.4 Biocodex Business Overview
10.14.5 Biocodex Recent Developments
10.15 Eli Lilly and Company
10.15.1 Eli Lilly and Company Insomnia Therapy Basic Information
10.15.2 Eli Lilly and Company Insomnia Therapy Product Overview
10.15.3 Eli Lilly and Company Insomnia Therapy Product Market Performance
10.15.4 Eli Lilly and Company Business Overview
10.15.5 Eli Lilly and Company Recent Developments
10.16 Ebb Therapeutics
10.16.1 Ebb Therapeutics Insomnia Therapy Basic Information
10.16.2 Ebb Therapeutics Insomnia Therapy Product Overview
10.16.3 Ebb Therapeutics Insomnia Therapy Product Market Performance
10.16.4 Ebb Therapeutics Business Overview
10.16.5 Ebb Therapeutics Recent Developments
11 Insomnia Therapy Market Forecast by Region
11.1 Global Insomnia Therapy Market Size Forecast
11.2 Global Insomnia Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Insomnia Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Insomnia Therapy Market Size Forecast by Region
11.2.4 South America Insomnia Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Insomnia Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Insomnia Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Insomnia Therapy by Type (2025-2032)
12.1.2 Global Insomnia Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Insomnia Therapy by Type (2025-2032)
12.2 Global Insomnia Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Insomnia Therapy Sales (K Units) Forecast by Application
12.2.2 Global Insomnia Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Insomnia Therapy Market Size Comparison by Region (M USD)
Table 5. Global Insomnia Therapy Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Insomnia Therapy Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Insomnia Therapy Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Insomnia Therapy Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2022)
Table 10. Global Market Insomnia Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Insomnia Therapy Sales Sites and Area Served
Table 12. Manufacturers Insomnia Therapy Product Type
Table 13. Global Insomnia Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Insomnia Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Insomnia Therapy Market Challenges
Table 22. Global Insomnia Therapy Sales by Type (K Units)
Table 23. Global Insomnia Therapy Market Size by Type (M USD)
Table 24. Global Insomnia Therapy Sales (K Units) by Type (2019-2025)
Table 25. Global Insomnia Therapy Sales Market Share by Type (2019-2025)
Table 26. Global Insomnia Therapy Market Size (M USD) by Type (2019-2025)
Table 27. Global Insomnia Therapy Market Size Share by Type (2019-2025)
Table 28. Global Insomnia Therapy Price (USD/Unit) by Type (2019-2025)
Table 29. Global Insomnia Therapy Sales (K Units) by Application
Table 30. Global Insomnia Therapy Market Size by Application
Table 31. Global Insomnia Therapy Sales by Application (2019-2025) & (K Units)
Table 32. Global Insomnia Therapy Sales Market Share by Application (2019-2025)
Table 33. Global Insomnia Therapy Sales by Application (2019-2025) & (M USD)
Table 34. Global Insomnia Therapy Market Share by Application (2019-2025)
Table 35. Global Insomnia Therapy Sales Growth Rate by Application (2019-2025)
Table 36. Global Insomnia Therapy Sales by Region (2019-2025) & (K Units)
Table 37. Global Insomnia Therapy Sales Market Share by Region (2019-2025)
Table 38. North America Insomnia Therapy Sales by Country (2019-2025) & (K Units)
Table 39. Europe Insomnia Therapy Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Insomnia Therapy Sales by Region (2019-2025) & (K Units)
Table 41. South America Insomnia Therapy Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Insomnia Therapy Sales by Region (2019-2025) & (K Units)
Table 43. Global Insomnia Therapy Production (K Units) by Region (2019-2025)
Table 44. Global Insomnia Therapy Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Insomnia Therapy Revenue Market Share by Region (2019-2025)
Table 46. Global Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Merck and Co. Insomnia Therapy Basic Information
Table 52. Merck and Co. Insomnia Therapy Product Overview
Table 53. Merck and Co. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Merck and Co. Business Overview
Table 55. Merck and Co. Insomnia Therapy SWOT Analysis
Table 56. Merck and Co. Recent Developments
Table 57. Sanofi Insomnia Therapy Basic Information
Table 58. Sanofi Insomnia Therapy Product Overview
Table 59. Sanofi Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Sanofi Business Overview
Table 61. Sanofi Insomnia Therapy SWOT Analysis
Table 62. Sanofi Recent Developments
Table 63. Pfizer Insomnia Therapy Basic Information
Table 64. Pfizer Insomnia Therapy Product Overview
Table 65. Pfizer Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Pfizer Insomnia Therapy SWOT Analysis
Table 67. Pfizer Business Overview
Table 68. Pfizer Recent Developments
Table 69. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Basic Information
Table 70. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Overview
Table 71. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Takeda Pharmaceutical Company Ltd. Business Overview
Table 73. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 74. Purdue Pharmaceuticals L.P. Insomnia Therapy Basic Information
Table 75. Purdue Pharmaceuticals L.P. Insomnia Therapy Product Overview
Table 76. Purdue Pharmaceuticals L.P. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Purdue Pharmaceuticals L.P. Business Overview
Table 78. Purdue Pharmaceuticals L.P. Recent Developments
Table 79. Eisai Insomnia Therapy Basic Information
Table 80. Eisai Insomnia Therapy Product Overview
Table 81. Eisai Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Eisai Business Overview
Table 83. Eisai Recent Developments
Table 84. Co. Ltd. Insomnia Therapy Basic Information
Table 85. Co. Ltd. Insomnia Therapy Product Overview
Table 86. Co. Ltd. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Co. Ltd. Business Overview
Table 88. Co. Ltd. Recent Developments
Table 89. Meda Consumer Healthcare Insomnia Therapy Basic Information
Table 90. Meda Consumer Healthcare Insomnia Therapy Product Overview
Table 91. Meda Consumer Healthcare Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Meda Consumer Healthcare Business Overview
Table 93. Meda Consumer Healthcare Recent Developments
Table 94. Pernix Therapeutics Insomnia Therapy Basic Information
Table 95. Pernix Therapeutics Insomnia Therapy Product Overview
Table 96. Pernix Therapeutics Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Pernix Therapeutics Business Overview
Table 98. Pernix Therapeutics Recent Developments
Table 99. Vanda Pharmaceuticals Insomnia Therapy Basic Information
Table 100. Vanda Pharmaceuticals Insomnia Therapy Product Overview
Table 101. Vanda Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Vanda Pharmaceuticals Business Overview
Table 103. Vanda Pharmaceuticals Recent Developments
Table 104. ECR Pharmaceuticals Insomnia Therapy Basic Information
Table 105. ECR Pharmaceuticals Insomnia Therapy Product Overview
Table 106. ECR Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. ECR Pharmaceuticals Business Overview
Table 108. ECR Pharmaceuticals Recent Developments
Table 109. Fidia Farmaceutici Insomnia Therapy Basic Information
Table 110. Fidia Farmaceutici Insomnia Therapy Product Overview
Table 111. Fidia Farmaceutici Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Fidia Farmaceutici Business Overview
Table 113. Fidia Farmaceutici Recent Developments
Table 114. Dainippon Sumitomo Insomnia Therapy Basic Information
Table 115. Dainippon Sumitomo Insomnia Therapy Product Overview
Table 116. Dainippon Sumitomo Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 117. Dainippon Sumitomo Business Overview
Table 118. Dainippon Sumitomo Recent Developments
Table 119. Biocodex Insomnia Therapy Basic Information
Table 120. Biocodex Insomnia Therapy Product Overview
Table 121. Biocodex Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 122. Biocodex Business Overview
Table 123. Biocodex Recent Developments
Table 124. Eli Lilly and Company Insomnia Therapy Basic Information
Table 125. Eli Lilly and Company Insomnia Therapy Product Overview
Table 126. Eli Lilly and Company Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 127. Eli Lilly and Company Business Overview
Table 128. Eli Lilly and Company Recent Developments
Table 129. Ebb Therapeutics Insomnia Therapy Basic Information
Table 130. Ebb Therapeutics Insomnia Therapy Product Overview
Table 131. Ebb Therapeutics Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 132. Ebb Therapeutics Business Overview
Table 133. Ebb Therapeutics Recent Developments
Table 134. Global Insomnia Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 135. Global Insomnia Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 136. North America Insomnia Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 137. North America Insomnia Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 138. Europe Insomnia Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 139. Europe Insomnia Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 140. Asia Pacific Insomnia Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 141. Asia Pacific Insomnia Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 142. South America Insomnia Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 143. South America Insomnia Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 144. Middle East and Africa Insomnia Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 145. Middle East and Africa Insomnia Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 146. Global Insomnia Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 147. Global Insomnia Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 148. Global Insomnia Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 149. Global Insomnia Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 150. Global Insomnia Therapy Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Insomnia Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Insomnia Therapy Market Size (M USD), 2019-2032
Figure 5. Global Insomnia Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Insomnia Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Insomnia Therapy Market Size by Country (M USD)
Figure 11. Insomnia Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Insomnia Therapy Revenue Share by Manufacturers in 2023
Figure 13. Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Insomnia Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Insomnia Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Insomnia Therapy Market Share by Type
Figure 18. Sales Market Share of Insomnia Therapy by Type (2019-2025)
Figure 19. Sales Market Share of Insomnia Therapy by Type in 2023
Figure 20. Market Size Share of Insomnia Therapy by Type (2019-2025)
Figure 21. Market Size Market Share of Insomnia Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Insomnia Therapy Market Share by Application
Figure 24. Global Insomnia Therapy Sales Market Share by Application (2019-2025)
Figure 25. Global Insomnia Therapy Sales Market Share by Application in 2023
Figure 26. Global Insomnia Therapy Market Share by Application (2019-2025)
Figure 27. Global Insomnia Therapy Market Share by Application in 2023
Figure 28. Global Insomnia Therapy Sales Growth Rate by Application (2019-2025)
Figure 29. Global Insomnia Therapy Sales Market Share by Region (2019-2025)
Figure 30. North America Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Insomnia Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Insomnia Therapy Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Insomnia Therapy Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Insomnia Therapy Sales Market Share by Country in 2023
Figure 37. Germany Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Insomnia Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Insomnia Therapy Sales Market Share by Region in 2023
Figure 44. China Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Insomnia Therapy Sales and Growth Rate (K Units)
Figure 50. South America Insomnia Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Insomnia Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Insomnia Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Insomnia Therapy Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Insomnia Therapy Production Market Share by Region (2019-2025)
Figure 62. North America Insomnia Therapy Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Insomnia Therapy Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Insomnia Therapy Production (K Units) Growth Rate (2019-2025)
Figure 65. China Insomnia Therapy Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Insomnia Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Insomnia Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Insomnia Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Insomnia Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Insomnia Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Insomnia Therapy Market Share Forecast by Application (2025-2032)
